Background: New sepsis and septic shock definitions could change the epidemiology of sepsis because of differences in criteria. We therefore compared the sepsis populations identified by the old and new definitions. Methods: We used a high-quality, national, intensive care unit (ICU) database of 654 918 consecutive admissions to 189 adult ICUs in England, from January 2011 to December 2015. Primary outcome was acute hospital mortality. We compared old (Sepsis-2) and new (Sepsis-3) incidence, outcomes, trends in outcomes, and predictive validity of sepsis and septic shock populations. Results: From among 197 724 Sepsis-2 severe sepsis and 197 142 Sepsis-3 sepsis cases, we identified 153 257 Sepsis-2 septic shock and 39 262 Sepsis-3 septic shock cases. The extrapolated population incidence of Sepsis-3 sepsis and Sepsis-3 septic shock was 101.8 and 19.3 per 100 000 person-years, respectively, in 2015. Sepsis-2 severe sepsis and Sepsis-3 sepsis had similar incidence, similar mortality and showed significant risk-adjusted improvements in mortality over time. Sepsis-3 septic shock had a much higher Acute Physiology And Chronic Health Evaluation II (APACHE II) score, greater mortality and no risk-adjusted trends in mortality improvement compared with Sepsis-2 septic shock. ICU admissions identified either as Sepsis-3 sepsis or septic shock and as Sepsis-2 severe sepsis or septic shock had significantly greater risk-adjusted odds of death compared with non-sepsis admissions (P<0.001). The predictive validity was greatest for Sepsis-3 septic shock. Conclusions: In an ICU database, compared with Sepsis-2, Sepsis-3 identifies a similar sepsis population with 92% overlap and much smaller septic shock population with improved predictive validity.
severe sepsis 3 and, for the first time, provided specific criteria for operationalizing the definitions. Organ dysfunction was operationalized using the total Sequential (Sepsis-related) Organ Failure Assessment (SOFA) score 1 4 and explicit criteria were proposed to define septic shock, harmonizing multiple criteria used in the literature. 2 5 Understanding the impact of changes in definitions on updated sepsis epidemiology is necessary to inform clinical care, future research and healthcare planning.
In this context, we tested the impact of the new sepsis definitions on epidemiology, by comparing Sepsis-2 severe sepsis/ septic shock and Sepsis-3 sepsis/septic shock populations derived from the same high-quality national ICU database that covers 96% of the adult general ICUs and combined ICUs/highdependency units in England. We compared the incidence, deaths, ICU and general population extrapolations, annual trends and predictive increment for acute hospital mortality of Sepsis-2 severe sepsis/septic shock and Sepsis-3 sepsis/septic shock over a 5 yr period between January 2011 and December 2015.
Methods

Data source
The Case Mix Programme is the national clinical audit for adult general ICUs in England. For consecutive admissions, trained data collectors collect sociodemographic, comorbidity and physiological data to precise rules and definitions, during the first 24 h following admission to ICU. Diagnostic data are determined clinically and coded using the hierarchical Intensive Care National Audit & Research Centre (ICNARC) Coding Method. 6 Collected data undergo extensive local and central validation prior to pooling into the Case Mix Programme Database (CMPD). Support for the collection and use of these data has been obtained under Section 251 of the National Health Service Act 2006 [approval number: PIAG 2-10(f)/2005]. 7 
Case definitions
Our study evaluated sepsis and septic shock during the first 24 h following ICU admission. Sepsis-2 severe sepsis and septic shock have been operationalized in several different ways, whereas Sepsis-3 provided specific criteria, which we followed as closely as possible. We identified presence of infection from the reported primary (mandated) and secondary (optional) reasons for ICU admission, derived SIRS criteria and organ dysfunctions (based on SOFA score) using raw physiological and laboratory data from the first 24 h following ICU admission. For organs where the relevant physiology to define SOFA were not available, we derived organ dysfunction based on receipt of organ support, according to national Critical Care Minimum Dataset (CCMDS) definitions. As SOFA score categorizes organ function from 0 (normal) to 4 (most abnormal), 4 we used SOFA score !1 as organ dysfunction to define Sepsis-2 severe sepsis as proposed by Levy and colleagues 3 (page 1253). Our operationalizations of the Sepsis-2 and Sepsis-3 definitions are described in Table 1 .
Analysis
After describing the Sepsis-2 and Sepsis-3 populations, we compared the trends in incidence, mortality and predictive validity of Sepsis-3 sepsis and septic shock. As unmeasured physiology was <5% in all sepsis case definitions data fields, we assumed unmeasured physiology to be normal. The primary outcome was all-cause acute hospital mortality. As missing data was <0.5% for the primary outcome, we performed complete case analyses in regression models, assuming missing data were missing at random, conditional on the model covariates.
Trends in incidence and extrapolations
We estimated the annual number of admissions to ICUs in England between January 2011 and December 2015 with sepsis and septic shock (by Sepsis-2 and Sepsis-3 definitions) by extrapolating the actual numbers for participating ICUs to the total number of ICUs in England for each year, as reported previously. 7 We converted these extrapolated numbers to population incidences (overall and by age categories and comorbidity status) using mid-year population estimates obtained from the Office for National Statistics.
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Trends in and risk factors for acute hospital mortality
We calculated unadjusted and adjusted trends in acute hospital mortality over the 5 yr study period for sepsis and septic shock (by Sepsis-2 and Sepsis-3 definitions) using logistic regression. Risk-adjusted trends were compared using four separate logistic regression models that adjusted for admission year, age, sex, ethnicity, severe co-morbidity [defined according to Acute Physiology And Chronic Health Evaluation (APACHE) II 9 ] functional status, surgical status, illness severity (APACHE II acute physiology score 9 ) and infection site. 7 
Assessment of predictive validity
We assessed the improvement in predictive validity both qualitatively, by comparing the difference in illness severity and mortality between the populations identified by Sepsis-2 and Sepsis-3, and quantitatively, using logistic regression models. For the logistic regression approach to be valid, the baseline model must use well-established risk predictors and outcomes as originally intended and the addition of the sepsis or septic shock category as a new predictor must improve model performance for the outcome predicted. 10 Thus, we derived a baseline model for acute hospital mortality, adjusted for admission year, age, sex, ethnicity, severe co-morbidity, functional status, surgical status and illness severity, using the overall population of all ICU admissions. Then, we compared the additional odds of dying from sepsis/septic shock compared with the non-sepsis population [adjusted odds ratios (OR)] and the increment in model fit using change in area under the curve (D-AUC), Bayesian Information Criterion (D-BIC) and Brier Scores when adding sepsis and septic shock (by Sepsis-2 and Sepsis-3 definitions) as new binary predictors within nested models.
Editor's key points
• Disease and syndrome definitions are somewhat arbitrary and differences in epidemiology can occur.
• The efficiency of medical research is enhanced when agreed disease and outcome criteria are used.
• Abandoning SIRS as the starting point for sepsis diagnosis does not alter the incidence as most patients with organ dysfunction also tend to have SIRS.
• Sepsis-3 septic shock is a high risk of death population.
Sensitivity analysis
We performed two sensitivity analyses. First, we excluded patients with severe comorbidity, to account for the change in SOFA score of 2 required for operationalizing the Sepsis-3 criteria. The rationale for this analysis is that patients with comorbidity may have baseline organ dysfunction that could potentially contribute to SOFA score. Second, we reassessed all four regression models of predictive validity without including illness severity (APACHE II acute physiology score). The rationale for this analysis is that including illness severity in our original analyses may mask the incremental change in discrimination provided by the presence of organ dysfunction to diagnose sepsis.
All logistic regression models excluded readmissions of the same patient during the same hospital stay, used only admission day APACHE II acute physiology score for severity of illness adjustment (to avoid double weighting of organ dysfunction in models as the score includes respiratory, renal, hypotension and Glasgow coma score variables), were fitted with robust standard errors to account for clustering by ICU, and were reported as OR with 95% confidence intervals (CI). Reported Pvalues are two-sided and a P-value <0.05 was considered a statistically significant result. Continuous data were summarized as mean and standard deviation (SD), where normally distributed, and median and inter-quartile range, where not. Categorical data were presented as frequency and percentage. All analyses were performed using Stata/SE Version 14.2 (StataCorp LP, College Station, TX, USA). Table S1 ). Among the sepsis cases, 189 243 met both definitions (92.0% of those meeting either definition) with 4.1% of Sepsis-2 severe sepsis cases not meeting stricter organ dysfunction criteria for Sepsis-3 and 4.0% of Sepsis-3 sepsis cases being SIRS negative. Among the sepsis admissions, there were 153 257 (77.5%) Sepsis-2 septic shock and 39 262 (19.9%) Sepsis-3 septic shock cases with 0.01% of Sepsis-3 septic shock cases being SIRS negative (Fig. 1) . The distributions of age, sex, dependency status, ethnicity, presence of severe co-morbidity, surgical status and admission source were comparable between cohorts. Respiratory was the most common infection site and organ dysfunction in all cohorts with comparable distributions of other infection sites and organ dysfunctions. The acute illness severity, serum lactate concentrations and hospital mortality were higher in septic shock cohorts, with greatest severity in Sepsis-3 septic shock (Table 2; Fig. 2 ). Sepsis patients identified only by Sepsis-3 were older, with greater illness severity [APACHE II score mean (SD) 15.1 (7.2) vs 9.7 (3.9)] and higher mortality (22.3% vs 7.0%), when compared with those patients identified only by Sepsis-2 (Supplementary Table S2 ). The incidence of, and mortality from, Sepsis-2 severe sepsis, Sepsis-2 septic shock, Sepsis-3 sepsis and Sepsis-3 septic shock increased with age ( Fig. 3) .
Results
Descriptive comparison
Trends in incidence
The Sepsis-2 severe sepsis and Sepsis-3 sepsis accounted for a third of admissions to adult general ICUs in England over the 5 yr period. The extrapolated population incidence increased similarly for both from 88 to 102 per 100 000 person-years. The Sepsis-2 septic shock and Sepsis-3 septic shock accounted for 23.4% and 6.0%, respectively, of admissions to adult general For defining Sepsis-2 and Sepsis-3 septic shock, we used highest blood lactate post-intensive care unit (ICU) admission and use of vasoactive drugs. The systemic inflammatory response syndrome (SIRS) criteria are detailed in the online supplement. For defining severe sepsis as per Sepsis-2 definitions, we followed the recommendations proposed by Levy and colleagues3 and we treated a Sequential Organ Failure Assessment (SOFA) score of 1 or more as organ dysfunction (page 1253 in Levy and colleagues). 3 As the baseline organ dysfunction is unknown in our study cohort, we assumed the baseline organ dysfunction was zero, as recommended in the Sepsis-3 consensus definitions (page 805 in Singer and colleagues) 1 and performed sensitivity analyses by excluding patients with a pre-existing comorbidity. We used a modified SOFA score to generate organ dysfunction. We derived respiratory, renal, cardiovascular, and haematological SOFA, as recommended by SOFA score categories, and recoded them as 0, 1 or ! 2 for each organ system. Neurological dysfunction was defined using Glasgow Coma Scale, with a score of 1 given for Glasgow Coma Score between 13 and 14 and a score !2 was for Glasgow Coma Score <13 and/or sedated/paralysed for the first 24 h. As we did not have bilirubin to define hepatic dysfunction, we used receipt of advanced liver support and coded that as hepatic SOFA score of ! 2. Advanced liver support is defined as acute on chronic hepatocellular failure requiring management of coagulopathy and/or portal hypertension (including liver purification and detoxification techniques). Cardiovascular dysfunction was derived as systolic blood pressure <90 mm Hg or mean arterial pressure <70 mm Hg or need for vasopressors to maintain blood pressure, identified by receipt of advanced cardiovascular support Table 2 Case mix characteristics for admissions to adult general intensive care units (ICU) in England with sepsis and septic shock (by Sepsis-2 and Sepsis-3 definitions). Adjusted OR (95% CI) refers to the additional risk of death because of sepsis or septic shock when compared with non-sepsis admissions using a fully adjusted logistic regression model. The regression models for Sepsis-3 sepsis and Sepsis-3 Septic shock are shown in Supplementary Tables S4 and S5 . We used a modified Sequential Organ Failure Assessment (SOFA) score to generate organ dysfunction (see Table 1 ). † DAUC refers to the comparison of AUC between the two models with and without sepsis/septic shock category. ‡ jDBICj refers to the absolute difference in Bayesian Information Criterion between the two models: first without sepsis/ septic shock category, and second with sepsis/septic shock category. A higher score points towards an improved regression model fit when adding the sepsis/septic shock variable. Any jDBICj value >10 provides very strong support for the model when comparing model fits for the outcome.
¶ Brier score is an aggregate measure of disagreement between the observed outcome and a model based prediction with a perfect prediction value of 0, a score of 0.25 for 50/50 prediction and a score of 0.2225 equates to P¼0.65. SD, standard deviation; n, number; ED, Emergency department; APACHE II, Acute Physiology and Chronic Health Evaluation II; MDH, Musculoskeletal, Dermatological, Haematological; serum lactate, highest serum lactate concentrations measured in blood in the first 24 h of ICU admission; SIRS, systemic inflammatory response syndrome; IQR, inter-quartile range; LOS, length of stay; OR, odds ratio; 95% CI, 95% confidence intervals; AUC, area under the receiver operating characteristic curve ICUs in England over the 5 yr period. Sepsis-2 septic shock accounted for three-quarters of the severe sepsis population and the extrapolated population incidence increased from 69 to 79 per 100 000 person-years. In contrast, Sepsis-3 septic shock was only one-fifth of the sepsis population and with minimal change in the extrapolated population incidence over the 5 yr period (approximately 19 per 100 000 person-years) (Supplementary Table S3 ; Fig. 4 ).
Trends in, and risk factors for, acute hospital mortality
The acute hospital mortality for Sepsis-2 severe sepsis and Sepsis-3 sepsis were similar and decreased from 33% in 2011 to 30% in 2015. The acute hospital mortality for Sepsis-2 septic shock decreased from 37% in 2011 to 33% in 2015. In contrast, the acute hospital mortality for Sepsis-3 septic shock changed from 57% in 2011 to 56% in 2015. The extrapolated numbers of deaths are shown in Supplementary Fig. S1 . The rate of improvement in unadjusted and risk-adjusted acute hospital mortality was significant for Sepsis-2 severe sepsis, Sepsis-3 sepsis and for Sepsis-2 septic shock. In contrast, no statistically significant trends in unadjusted or risk-adjusted acute hospital mortality were observed for patients meeting the Sepsis-3 septic shock case definition (Supplementary Table S4 ). The independent risk factors for acute hospital mortality identified for Sepsis-3 sepsis and septic shock were increasing age, male, presence of severe comorbidity, increasing dependency and worsening APACHE II acute physiology score. Compared with the non-surgical group, surgical populations had lower risk of death. Compared with respiratory tract infections, gastrointestinal and genitourinary infections had lower risk of death (Supplementary Tables S5 and S6 ).
Assessment of predictive validity
As shown in Figure 2 , Sepsis-2 severe sepsis and Sepsis-3 sepsis are similar cohorts, but Sepsis-3 septic shock was a more severe illness with a greater risk of death compared with Sepsis-2 a significantly better predictive increment with the Sepsis-3 septic shock diagnosis. The increment in AUC and BIC was greatest for Sepsis-3 septic shock, with a Brier score of 0.119 (Table 2) .
Sensitivity analysis
The results of sensitivity analyses were consistent with the primary analyses. We observed improving trends risk-adjusted acute hospital mortality only in Sepsis-3 sepsis, OR per year 0. were identified only by Sepsis-2 severe sepsis and n¼7899 (3.8%) were identified only by Sepsis-3 sepsis operationalization. There were n¼39 262 Sepsis-3 septic shock cases and n¼153 257 Sepsis-2 septic shock cases. Among the 153 623 septic shock cases identified by either of the definitions, n¼114 727 were identified only by Sepsis-2 septic shock and n¼366 were identified by only by Sepsis-2 septic shock operationalization. Please note that Sepsis-2 septic shock and Sepsis-3 septic shock populations are included within the broader Sepsis-2 severe sepsis and Sepsis-3 sepsis categories, respectively.
severe comorbidity. The highest increment in predictive validity was for Sepsis-3 septic shock in the regression models without illness severity (Supplementary Table S7 ).
Discussion
In ICUs in England, Sepsis-2 severe sepsis and Sepsis-3 sepsis definitions identify similar cohorts with 92% overlap. Between 2011 and 2015, incidence increased and risk-adjusted acute hospital mortality improved. Sepsis-3 septic shock criteria identify a much smaller population compared with Sepsis-2 septic shock, with very little increase in incidence between 2011 and 2015. When compared with non-sepsis admissions after risk adjustment, Sepsis-3 sepsis has 1.15 times, and Sepsis-3 septic shock 2.42 times, greater odds of death. The extrapolated population incidences of Sepsis-3 sepsis and septic shock in 2015 were 102 and 19 per 100 000 person-years, respectively. The corresponding annual adult ICU caseloads in England in 2015 were 45 200 and 8600 patients, respectively. The descriptive epidemiology of Sepsis-3 sepsis in ICU setting is similar to that described previously for Sepsis-2 severe sepsis. 2 7 The incidence and mortality of Sepsis-3 sepsis and septic shock increase significantly with age and comorbidity.
11 12 The overall frequency of Sepsis-3 septic shock (six per 100 ICU admissions) was similar to previous reports in other ICU settings using the International Classification of Diseases codes for estimating septic shock incidence between 1993 and 2000. 2 13 The reduction in proportion of Sepsis-3 septic shock observed in our study is supported by the recently published secondary analysis of Vasopressin and Septic Shock Trial. 14 The increasing population incidence and decreasing trends in mortality of Sepsis-3 sepsis are consistent with what we would expect from our previous Sepsis-2 publications. 7 15 Sepsis-3 sepsis identifies SIRS-positive and SIRS-negative patients but with a greater degree of organ dysfunction. The higher mortality in the population identified only by Sepsis-3 (Supplementary Table S1 ) is secondary to greater severity of illness, which is an example of predictive validity intended by Sepsis-3 definitions. 1 16 We present one of the first direct comparisons of old and new sepsis epidemiology, using a high-quality national ICU database with >90% potential ICU population coverage. We used primary or secondary reasons for admission to identify infection, to maximize sensitivity for identifying sepsis cases. We operationalized old and new definitions using raw physiology data and used consecutive admissions over a 5 yr period between 2011 and 2015, overcoming the challenges often highlighted with using insurance claims or reimbursement formulae for reporting sepsis epidemiology. 7 17-19 Editorials have argued that abandoning SIRS may result in delayed identification of high-risk sepsis population. [20] [21] [22] The rationale for abandoning SIRS criteria as the starting point of the nested sepsis illness model includes lack of discriminant validity, 1 16 23-25 occurrence of SIRS-negative sepsis in the ICU setting 7 26 and well-documented early immunosuppression in sepsis. 27 From our analysis, in the UK ICU setting, abandoning SIRS as the starting point for sepsis diagnosis does not alter the incidence as most patients with organ dysfunction also tend to have SIRS.
The population identified by Sepsis-3 sepsis has a higher mortality, which is explained by greater burden of organ dysfunction when using SOFA !2 points as criteria. Admittedly, our results from ICU settings in England are not applicable to resource-limited settings, 2 sepsis in general wards 28 and in settings where there is established lactate screening as part of quality improvement initiatives. 29 Our study has several limitations. Our study reports the epidemiology of adult ICU admissions with sepsis using data in the first 24 h of ICU admission, which potentially underestimates incidence. As England has among the lowest per capita ICU bed provision in Europe (3.5 to 7.4 per 100 000 population), 30 31 probability of underestimation is low as organ dysfunction will often be present on admission day. We derived our organ dysfunction using a modified SOFA score, as not all physiological parameters were present in the dataset. Although we did not use change in SOFA score as a result of lack of pre-admission organ dysfunction variables, we used the method recommended by the Sepsis-3 definitions paper for operationalizing SOFA where baseline organ dysfunction is not available and performed sensitivity analysis to support our inferences. 1 Although we used a sensitive definition for Sepsis-2 septic shock that potentially overestimates the Sepsis-2 septic shock incidence, our operationalization was used in three recent resuscitation trials 32 and was a common operationalization method in epidemiological studies of septic shock. 2 We do not have data on fluid resuscitation in all patients. However, in the recently completed UK-based, early, goaldirected therapy trial, 97% of patient received at least 2000 ml of fluid between hospitalization and prior to randomization, 33 implying that most patients in the study requiring inotropes would have received some form of resuscitation fluids. This assumption is also supported by the recent UK-wide National Confidential Enquiry Into Patient Outcome and Death report on Age and severe comorbidity-specific extrapolated population incidence of, and age-category-specific crude acute hospital mortality from Sepsis-2 severe sepsis, Sepsis-2 septic shock, Sepsis-3 sepsis and Sepsis-3 septic shock. P<0.001 for trends in age-specific mortality rates for Sepsis-2 severe sepsis (A), Sepsis-2 septic shock (B), Sepsis-3 sepsis (C) and Sepsis-3 septic shock (D). Admissions without severe comorbidity were more common than admissions with severe comorbidities as defined using APACHE II definitions. PMH, past medical history of severe comorbidity.
sepsis, which highlighted 82.5% of patients received resuscitation fluids prior to critical care admission. 34 To partially account for these issues, we used the admission day APACHE II acute physiology score that contains components of organ dysfunction weighted in the regression models presented and used acute hospital mortality as primary outcome, which is what APACHE II score is calibrated for. All our regression models had AUC >0.75 and Brier scores <0.2, implying good model fit and performance. 10 Although the clinical care, the decision to accept patient for ICU care and changes in process of care could influence incidence and outcomes over the study period, understanding the impact of these elements was not our study objective and must be considered for future research. Despite the limitations, our study provides a conceptual framework for future work in this area. Our in-depth descriptive epidemiology of Sepsis-3 generates numerous fundamental analytical epidemiology questions. For example, Sepsis-3 sepsis focuses on organ dysfunction as a core illness characteristic, but interventional trials aimed at improving organ dysfunction have not consistently resulted in survival benefit. 35 36 We confirm that Sepsis-3 septic shock is a high risk of death population, which can be interpreted as better predictive validity and argued as prognostic enrichment resulting in potentially greater trial efficiency. 37 However, there is no proof that this cohort will necessarily have improved treatment response to trial interventions, which is predictive enrichment. 37 38 Thus, it is important to study the magnitude of risk reduction that is feasible in these populations, an essential component of future trial design. This updated epidemiology has implications for future trial design.
Conclusions
Our study shows that Sepsis-2 and Sepsis-3 definitions identified similar populations of sepsis cases with 92% overlap in ICU settings in England. Sepsis-3 also identifies a SIRS-negative population and a much smaller septic shock subpopulation with a greater risk of death, which highlight improved predictive validity of the Sepsis-3 definitions. 
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